EquityZen Growth Technology Fund LLC - Series 657
Raised
$930K
Investors
38
Min Invest
$9,998
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 657 is a Delaware-based pooled investment vehicle filed by EquityZen Advisors on 2020-11-04, raising $930K from 38 investors under Rule 506(b) and 3(c)(1) exemptions. The fund requires a $10K minimum investment and is part of EquityZen's pre-IPO secondary market platform, which operates nearly 1,900 series-level SPVs providing access to private company equity.
This pre-IPO fund follows the standard EquityZen structure: a 506(b) private placement combined with 3(c)(1) exemption, targeting retail-accessible minimums ($10K) to aggregate investor capital into single-company exposure vehicles. The 38-investor count and sub-$1M raise are typical for EquityZen's series-level SPVs, which allow fragmented access to late-stage private equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
